vs
Side-by-side financial comparison of Armour Residential REIT, Inc. (ARR) and LIFECORE BIOMEDICAL, INC. \DE\ (LFCR). Click either name above to swap in a different company.
Armour Residential REIT, Inc. is the larger business by last-quarter revenue ($50.4M vs $31.1M, roughly 1.6× LIFECORE BIOMEDICAL, INC. \DE\). Armour Residential REIT, Inc. runs the higher net margin — 420.2% vs -32.1%, a 452.4% gap on every dollar of revenue. On growth, Armour Residential REIT, Inc. posted the faster year-over-year revenue change (297.9% vs -4.5%). Over the past eight quarters, Armour Residential REIT, Inc.'s revenue compounded faster (108.0% CAGR vs -0.1%).
Armour Residential REIT, Inc. is a U.S.-based real estate investment trust that primarily invests in agency residential mortgage-backed securities guaranteed by U.S. government-sponsored entities. It focuses on generating consistent long-term net income for shareholders via strategic asset management and active interest rate risk mitigation.
LIFECORE BIOMEDICAL, INC. is a biomedical firm focused on developing and manufacturing high-quality hyaluronic acid-based biomaterials. It operates three core segments: medical application products, pharmaceutical solutions, and personal care ingredients, with main markets spanning North America, Europe and the Asia-Pacific, supplying to leading medical device, pharmaceutical and cosmetic brand partners.
ARR vs LFCR — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $50.4M | $31.1M |
| Net Profit | $211.7M | $-10.0M |
| Gross Margin | — | 25.0% |
| Operating Margin | — | -9.9% |
| Net Margin | 420.2% | -32.1% |
| Revenue YoY | 297.9% | -4.5% |
| Net Profit YoY | 555.9% | -52.0% |
| EPS (diluted) | $2.43 | $-0.29 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $50.4M | — | ||
| Q3 25 | $38.5M | $31.1M | ||
| Q2 25 | $33.1M | — | ||
| Q1 25 | $36.3M | $35.2M | ||
| Q4 24 | $12.7M | $32.6M | ||
| Q3 24 | — | $24.7M | ||
| Q2 24 | $7.0M | — | ||
| Q1 24 | — | $35.7M |
| Q4 25 | $211.7M | — | ||
| Q3 25 | $159.3M | $-10.0M | ||
| Q2 25 | $-75.6M | — | ||
| Q1 25 | $27.3M | $-14.8M | ||
| Q4 24 | $-46.4M | $-6.6M | ||
| Q3 24 | — | $-16.2M | ||
| Q2 24 | $-48.4M | — | ||
| Q1 24 | — | $15.6M |
| Q4 25 | — | — | ||
| Q3 25 | — | 25.0% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 28.0% | ||
| Q4 24 | — | 34.0% | ||
| Q3 24 | — | 21.8% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 33.3% |
| Q4 25 | — | — | ||
| Q3 25 | — | -9.9% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -25.7% | ||
| Q4 24 | — | -6.0% | ||
| Q3 24 | — | -46.9% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | -2.5% |
| Q4 25 | 420.2% | — | ||
| Q3 25 | 413.5% | -32.1% | ||
| Q2 25 | -228.4% | — | ||
| Q1 25 | 75.2% | -42.0% | ||
| Q4 24 | -366.8% | -20.2% | ||
| Q3 24 | — | -65.7% | ||
| Q2 24 | -693.8% | — | ||
| Q1 24 | — | 43.8% |
| Q4 25 | $2.43 | — | ||
| Q3 25 | $1.49 | $-0.29 | ||
| Q2 25 | $-0.94 | — | ||
| Q1 25 | $0.32 | $-0.47 | ||
| Q4 24 | $-0.91 | $-0.25 | ||
| Q3 24 | — | $-0.53 | ||
| Q2 24 | $-1.05 | — | ||
| Q1 24 | — | $0.42 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $63.3M | $18.9M |
| Total DebtLower is stronger | — | $136.0M |
| Stockholders' EquityBook value | $2.3B | $-10.5M |
| Total Assets | $21.0B | $235.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $63.3M | — | ||
| Q3 25 | $44.2M | $18.9M | ||
| Q2 25 | $141.2M | — | ||
| Q1 25 | $49.1M | $5.4M | ||
| Q4 24 | $68.0M | $9.5M | ||
| Q3 24 | — | — | ||
| Q2 24 | $126.6M | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | $136.0M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $124.9M | ||
| Q4 24 | — | $111.3M | ||
| Q3 24 | — | $106.3M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $97.1M |
| Q4 25 | $2.3B | — | ||
| Q3 25 | $2.1B | $-10.5M | ||
| Q2 25 | $1.7B | — | ||
| Q1 25 | $1.7B | $2.2M | ||
| Q4 24 | $1.4B | $15.4M | ||
| Q3 24 | — | $-3.9M | ||
| Q2 24 | $1.2B | — | ||
| Q1 24 | — | $17.7M |
| Q4 25 | $21.0B | — | ||
| Q3 25 | $19.4B | $235.2M | ||
| Q2 25 | $16.2B | — | ||
| Q1 25 | $15.5B | $237.7M | ||
| Q4 24 | $13.5B | $255.4M | ||
| Q3 24 | — | $246.8M | ||
| Q2 24 | $10.1B | — | ||
| Q1 24 | — | $246.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 56.05× | ||
| Q4 24 | — | 7.20× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 5.49× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $124.2M | $1.8M |
| Free Cash FlowOCF − Capex | — | $25.0K |
| FCF MarginFCF / Revenue | — | 0.1% |
| Capex IntensityCapex / Revenue | — | 5.6% |
| Cash ConversionOCF / Net Profit | 0.59× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-16.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $124.2M | — | ||
| Q3 25 | $-37.8M | $1.8M | ||
| Q2 25 | $25.0M | — | ||
| Q1 25 | $101.5M | $1.2M | ||
| Q4 24 | $261.5M | $-6.1M | ||
| Q3 24 | — | $-613.0K | ||
| Q2 24 | $27.1M | — | ||
| Q1 24 | — | $-1.4M |
| Q4 25 | — | — | ||
| Q3 25 | — | $25.0K | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $-4.3M | ||
| Q4 24 | — | $-8.6M | ||
| Q3 24 | — | $-4.0M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $-7.8M |
| Q4 25 | — | — | ||
| Q3 25 | — | 0.1% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -12.1% | ||
| Q4 24 | — | -26.3% | ||
| Q3 24 | — | -16.3% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | -21.8% |
| Q4 25 | — | — | ||
| Q3 25 | — | 5.6% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 15.5% | ||
| Q4 24 | — | 7.5% | ||
| Q3 24 | — | 13.9% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 17.8% |
| Q4 25 | 0.59× | — | ||
| Q3 25 | -0.24× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 3.71× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | -0.09× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ARR
Segment breakdown not available.
LFCR
| Transferred At Point In Time | $26.6M | 85% |
| Transferred Over Time | $4.5M | 15% |
